STRUCTURE-ACTIVITY STUDY OF THE C-TERMINAL RESIDUE OF MEN-10207 TACHYKININ ANTAGONIST

被引:9
|
作者
ROVERO, P
QUARTARA, L
ASTOLFI, M
PATACCHINI, R
GIACHETTI, A
MAGGI, CA
机构
[1] A MENARINI PHARMACEUT,DEPT CHEM,I-50131 FLORENCE,ITALY
[2] A MENARINI PHARMACEUT,DEPT PHARMACOL,I-50131 FLORENCE,ITALY
[3] MENARINI SUD,DEPT PHARMACOL,POMEZIA,ITALY
关键词
NEUROKININ-A; NK-2 TACHYKININ RECEPTOR SUBTYPES; TACHYKININ ANTAGONISTS;
D O I
10.1016/0196-9781(92)90164-X
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The role of the C-terminal residue in the sequence of the NK-2- selective tachykinin antagonist, MEN 10207 (Asp-Tyr-D-Trp-Val-D-Trp-D-Trp-Arg-NH2). has been examined by systematic amino acid substitutions. Biological activity has been measured on two in vitro preparations chosen as paradigms of the recently described NK-2 receptor subtypes, namely the rabbit pulmonary artery and the hamster trachea, in order to define the structural requirements necessary for antagonist subtype selectivity. We conclude that in the presence of a C-terminal hydrophilic residue, affinity is maximal for the NK-2A subtype. while hydrophobic. bulky and aromatic residues increase affinity for the NK-2B subtype.
引用
收藏
页码:207 / 208
页数:2
相关论文
共 50 条
  • [31] Activity of the mitogenic Pasteurella multocida toxin requires an essential C-terminal residue
    Ward, PN
    Miles, AJ
    Sumner, IG
    Thomas, LH
    Lax, AJ
    INFECTION AND IMMUNITY, 1998, 66 (12) : 5636 - 5642
  • [32] STRUCTURE-ACTIVITY RELATIONSHIPS IN C-TERMINAL PART OF LUTEINIZING-HORMONE RELEASING HORMONE (LH-RH)
    FUJINO, M
    FUKUDA, T
    WHITE, WF
    YAMAZAKI, I
    SHINAGAW.S
    OBAYASHI, M
    NAKAYAMA, R
    RIPPEL, RH
    KOBAYASH.S
    KITADA, C
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1972, 49 (03) : 863 - &
  • [33] Identifying structural determinants of potency for analogs of apelin-13: Integration of C-terminal truncation with structure-activity
    Zhang, Yanyan
    Maitra, Rangan
    Harris, Danni L.
    Dhungana, Suraj
    Snyder, Rodney
    Runyon, Scott P.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2014, 22 (11) : 2992 - 2997
  • [34] C-terminal modified parathyroid hormone: Effects on structure and activity
    Potetinova, Z
    Barbier, JR
    Gardella, TG
    Dean, T
    Willick, GE
    BIOPOLYMERS, 2005, 80 (04) : 583 - 583
  • [35] C-terminal modified parathyroid hormone: Effects on structure and activity
    Potetinova, Zhanna
    Barbier, Jean-Rene
    Dean, Thomas
    Gardella, Thomas J.
    Willick, Gordon E.
    UNDERSTANDING BIOLOGY USING PEPTIDES, 2006, : 621 - +
  • [36] STRUCTURE ACTIVITY STUDIES OF THE C-TERMINAL REGION OF THE ENDOTHELINS AND THE SARAFOTOXINS
    DOHERTY, AM
    CODY, WL
    LEITZ, NL
    DEPUE, PL
    TAYLOR, MD
    RAPUNDALO, ST
    HINGORANI, GP
    MAJOR, TC
    PANEK, RL
    TAYLOR, DG
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1991, 17 : S59 - S61
  • [37] Evidence that the C-terminal tryptophan residue of bovine neutral endopeptidase is critical for enzyme activity
    Lee, MS
    Bhasker, CR
    Kumar, GK
    FASEB JOURNAL, 2003, 17 (04): : A152 - A152
  • [38] Role of the C-terminal tryptophan residue for the structure-function of the alphavirus capsid protein
    Skoging, U
    Liljeström, P
    JOURNAL OF MOLECULAR BIOLOGY, 1998, 279 (04) : 865 - 872
  • [39] C-Terminal Modification on the Immunomodulatory Activity, Antioxidant Activity, and Structure-Activity Relationship of Pulsed Electric Field (PEF)-Treated Pine Nut Peptide
    Zhang, Shuyu
    Dong, Liu
    Bao, Zhijie
    Lin, Songyi
    FOODS, 2022, 11 (17)
  • [40] Structure-activity mapping of ARHGAP36 reveals regulatory roles for its GAP homology and C-terminal domains
    Nano, Patricia R.
    Johnson, Taylor K.
    Kudo, Takamasa
    Mooney, Nancie A.
    Ni, Jun
    Demeter, Janos
    Jackson, Peter K.
    Chen, James K.
    PLOS ONE, 2021, 16 (05):